Can Omeros (Omer) stock rise 192% on rising earnings estimates?
The average of price targets set by Wall Street analysts indicates a potential upside of 192% in Omeros (OMER). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
When will Omeros Corporation report its Q4 earnings?
SEATTLE, February 24, 2022--Omeros Corporation (NASDAQ: OMER) today announced that the company will issue its fourth quarter and year-end financial results for the period ended December 31, 2021, on Tuesday, March 1, 2022, after the market closes.
What are analysts'price targets for Omeros'stock?
4 analysts have issued 12 month price objectives for Omeros' stock. Their forecasts range from $18.00 to $35.00. On average, they expect Omeros' stock price to reach $27.75 in the next year.
What is the upside for Omeros'stock?
6 Wall Street analysts have issued 1 year target prices for Omeros' shares. Their forecasts range from $5.00 to $100.00. On average, they expect Omeros' stock price to reach $31.40 in the next twelve months. This suggests a possible upside of 350.5% from the stock's current price.
Is Omeros stock a good buy?
Out of 4 analysts, 0 (0%) are recommending OMER as a Strong Buy, 1 (25%) are recommending OMER as a Buy, 2 (50%) are recommending OMER as a Hold, 0 (0%) are recommending OMER as a Sell, and 1 (25%) are recommending OMER as a Strong Sell. What is OMER's earnings growth forecast for 2022-2024?
Why is Omeros stock dropping?
Omeros stock is sinking today because the company told investors the FDA identified deficiencies that prevent the agency from taking the next step toward approving narsoplimab. This could be a minor case that isn't related to the drug candidate itself, but investors aren't taking any chances.
Will OMER stock recover?
Currently there's no upside potential for OMER, based on the analysts' average price target.
What does omeros do?
Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
Should I buy or sell Omeros stock right now?
6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Omeros in the last year. There are currently 2 sell rati...
What is Omeros' stock price forecast for 2022?
6 analysts have issued 1 year target prices for Omeros' stock. Their forecasts range from $4.00 to $100.00. On average, they expect Omeros' share p...
How has Omeros' stock price performed in 2022?
Omeros' stock was trading at $6.43 on January 1st, 2022. Since then, OMER stock has decreased by 67.5% and is now trading at $2.09. View the best...
When is Omeros' next earnings date?
Omeros is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022. View our earnings forecast for Omeros .
How were Omeros' earnings last quarter?
Omeros Co. (NASDAQ:OMER) issued its earnings results on Tuesday, May, 10th. The biopharmaceutical company reported ($0.56) EPS for the quarter, top...
Who are Omeros' key executives?
Omeros' management team includes the following people: Dr. Gregory A. Demopulos M.D. , Co-Founder, Chairman, CEO & Pres (Age 63, Pay $2.24M) Mr....
What is Gregory A. Demopulos' approval rating as Omeros' CEO?
17 employees have rated Omeros CEO Gregory A. Demopulos on Glassdoor.com . Gregory A. Demopulos has an approval rating of 74% among Omeros' employ...
Who are some of Omeros' key competitors?
Some companies that are related to Omeros include Johnson & Johnson (JNJ) , Eli Lilly and (LLY) , Pfizer (PFE) , AbbVie (ABBV) , Merck & Co.,...
What other stocks do shareholders of Omeros own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Omeros investors own include ACADIA Pharmaceuticals (ACAD)...
What is Omeros Corp?
What is the P/E ratio of Omeros?
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.
Where is Omeros located?
The P/E ratio of Omeros is -3.85, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Does Omeros pay dividends?
Omeros' mailing address is 201 ELLIOT AVENUE WEST, SEATTLE WA, 98119. The biopharmaceutical company can be reached via phone at (206) 676-5000 or via fax at 206-676-5005.
What is the Vickers top buyer and seller report?
Omeros does not currently pay a dividend.
Is Omeros oversold?
Daily – Vickers Top Buyers & Sellers for 11/24/2021 The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
What is Omeros Corporation?
Omeros (OMER) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
How many articles has the Fool written on Omeros?
Omeros Corporation is a clinical-stage Biopharmaceutical Company engaged in discovering developing and commercializing products focused on inflammation and disorders of the central nervous system.
How to calculate restricted stock?
The Fool has written over 100 articles on Omeros.
Who owns restricted shares of a company?
To calculate, start with total shares outstanding and subtract the number of restricted shares. Restricted stock typically is that issued to company insiders with limits on when it may be traded. A company's dividend expressed as a percentage of its current stock price.
How long are futures trading delayed?
Number of shares that are currently held by investors, including restricted shares owned by the company's officers and insiders as well as those held by the public.
How often do exchanges report short interest?
Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle.
